Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Classen

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2022
Additive value of [<sup>18</sup>F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndromeSabrina Katzdobler, Alexander Nitschmann, Henryk Barthel, et al.
JAMA|February 25, 2015
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhageJoji B Kuramatsu, Stefan T Gerner, Peter D Schellinger, et al.
Movement Disorders Clinical Practice|January 27, 2025
A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear PalsySonja Porsche, Martin Klietz, Stephan Greten, et al.
Nature Communications|March 16, 2022
Tau deposition patterns are associated with functional connectivity in primary tauopathiesNicolai Franzmeier, Matthias Brendel, Leonie Beyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 18, 2019
Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhageMaximilian I Sprügel, Jochen A Sembill, Joji B Kuramatsu, et al.
Journal of Neurology|October 6, 2023
The comorbidity and co-medication profile of patients with progressive supranuclear palsyStephan Greten, Florian Wegner, Ida Jensen, et al.
Brain : a Journal of Neurology|August 1, 2024
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease studyAna Westenberger, Volha Skrahina, Tatiana Usnich, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2022
Additive value of [<sup>18</sup>F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndromeSabrina Katzdobler, Alexander Nitschmann, Henryk Barthel, et al.
JAMA|February 25, 2015
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhageJoji B Kuramatsu, Stefan T Gerner, Peter D Schellinger, et al.
Movement Disorders Clinical Practice|January 27, 2025
A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear PalsySonja Porsche, Martin Klietz, Stephan Greten, et al.
Nature Communications|March 16, 2022
Tau deposition patterns are associated with functional connectivity in primary tauopathiesNicolai Franzmeier, Matthias Brendel, Leonie Beyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 18, 2019
Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhageMaximilian I Sprügel, Jochen A Sembill, Joji B Kuramatsu, et al.
Journal of Neurology|October 6, 2023
The comorbidity and co-medication profile of patients with progressive supranuclear palsyStephan Greten, Florian Wegner, Ida Jensen, et al.
Brain : a Journal of Neurology|August 1, 2024
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease studyAna Westenberger, Volha Skrahina, Tatiana Usnich, et al.
Pageof 18